>
Switch to:

PTC Therapeutics Total Assets

: $1,799.6 Mil (As of Mar. 2022)
View and export this data going back to 2013. Start your Free Trial

PTC Therapeutics's Total Assets for the quarter that ended in Mar. 2022 was $1,799.6 Mil.

Warning Sign:

If a company builds asset at 89.3% a year, faster than its revenue growth rate of 19% over the past 5 years, it means that the company may be getting less efficent.

During the past 12 months, PTC Therapeutics's average Total Assets Growth Rate was 7.90% per year. During the past 3 years, the average Total Assets Growth Rate was 9.30% per year. During the past 5 years, the average Total Assets Growth Rate was 89.30% per year. During the past 10 years, the average Total Assets Growth Rate was 78.70% per year.

During the past 11 years, PTC Therapeutics's highest 3-Year average Total Assets Growth Rate was 223.40%. The lowest was 4.60%. And the median was 67.60%.

Total Assets is connected with ROA %. PTC Therapeutics's annualized ROA % for the quarter that ended in Mar. 2022 was -27.12%. Total Assets is also linked to Revenue through Asset Turnover. PTC Therapeutics's Asset Turnover for the quarter that ended in Mar. 2022 was 0.08.


PTC Therapeutics Total Assets Historical Data

The historical data trend for PTC Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PTC Therapeutics Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Total Assets
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 391.65 1,119.22 1,623.78 2,208.28 1,938.06

PTC Therapeutics Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Total Assets Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,111.94 2,058.67 2,007.33 1,938.06 1,799.59

PTC Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

PTC Therapeutics's Total Assets for the fiscal year that ended in Dec. 2021 is calculated as

Total Assets=Total Equity (A: Dec. 2021 )+Total Liabilities (A: Dec. 2021 )
=1.438+1936.618
=1,938.1

PTC Therapeutics's Total Assets for the quarter that ended in Mar. 2022 is calculated as

Total Assets=Total Equity (Q: Mar. 2022 )+Total Liabilities (Q: Mar. 2022 )
=-90.581+1890.172
=1,799.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PTC Therapeutics  (NAS:PTCT) Total Assets Explanation

Total Assets is connected with ROA %.

PTC Therapeutics's annualized ROA % for the quarter that ended in Mar. 2022 is

ROA %=Net Income (Q: Mar. 2022 )/( (Total Assets (Q: Dec. 2021 )+Total Assets (Q: Mar. 2022 ))/ count )
=-506.904/( (1938.056+1799.591)/ 2 )
=-506.904/1868.8235
=-27.12 %

Note: The Net Income data used here is four times the quarterly (Mar. 2022) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

PTC Therapeutics's Asset Turnover for the quarter that ended in Mar. 2022 is

Asset Turnover
=Revenue (Q: Mar. 2022 )/( (Total Assets (Q: Dec. 2021 )+Total Assets (Q: Mar. 2022 ))/ count )
=148.735/( (1938.056+1799.591)/ 2 )
=148.735/1868.8235
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

PTC Therapeutics Total Assets Related Terms

Thank you for viewing the detailed overview of PTC Therapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


PTC Therapeutics Business Description

PTC Therapeutics logo
Industry
Healthcare » Biotechnology NAICS : 325412 SIC : 2834
Traded in Other Exchanges
Address
100 Corporate Court, South Plainfield, NJ, USA, 07080
PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
Executives
Southwell David P director C/O INOTEK PHARMACEUTICALS CORPORATION 91 HARTWELL AVENUE LEXINGTON MA 02421
Jacobson Allan Steven director PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Peltz Stuart Walter director, officer: Chief Executive Officer PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Utter Christine Marie officer: SVP, Finance & CAO C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Boulding Mark Elliott officer: Exec. VP and CLO C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Hill Emily Luisa officer: Chief Financial Officer C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Svoronos Dawn director C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105
Pauwels Eric officer: Chief Business Officer 550 HILLS DRIVE BEDMINSTER NJ 07921
Klein Matthew B. officer: Chief Development Officer C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Schmertzler Michael director 1300 VALLEY ROAD NEW CANAAN CT 06840
Souza Marcio officer: Chief Operating Officer C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Almstead Neil Gregory officer: Chief Technical Ops Officer C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Reeve Emma director C/O PAREXEL INTERNATIONAL CORPORATION 195 WEST STREET WALTHAM MA 02451
Steele Glenn Jr Md Phd director 250 TECHNOLOGY PARK LAKE MARY FL 32746-6232
Zeldis Jerome B director 8767 E. VIA DE VENTURA, SUITE 190 SCOTTSDALE AZ 85258

PTC Therapeutics Headlines

Other Sources

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)